全文获取类型
收费全文 | 4835篇 |
免费 | 261篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 84篇 |
妇产科学 | 75篇 |
基础医学 | 669篇 |
口腔科学 | 76篇 |
临床医学 | 232篇 |
内科学 | 1240篇 |
皮肤病学 | 94篇 |
神经病学 | 262篇 |
特种医学 | 149篇 |
外科学 | 878篇 |
综合类 | 11篇 |
预防医学 | 188篇 |
眼科学 | 25篇 |
药学 | 225篇 |
中国医学 | 5篇 |
肿瘤学 | 896篇 |
出版年
2023年 | 27篇 |
2022年 | 45篇 |
2021年 | 110篇 |
2020年 | 65篇 |
2019年 | 81篇 |
2018年 | 91篇 |
2017年 | 69篇 |
2016年 | 112篇 |
2015年 | 116篇 |
2014年 | 124篇 |
2013年 | 134篇 |
2012年 | 239篇 |
2011年 | 296篇 |
2010年 | 146篇 |
2009年 | 132篇 |
2008年 | 241篇 |
2007年 | 258篇 |
2006年 | 235篇 |
2005年 | 253篇 |
2004年 | 285篇 |
2003年 | 240篇 |
2002年 | 224篇 |
2001年 | 168篇 |
2000年 | 136篇 |
1999年 | 165篇 |
1998年 | 71篇 |
1997年 | 55篇 |
1996年 | 56篇 |
1995年 | 52篇 |
1994年 | 49篇 |
1993年 | 43篇 |
1992年 | 91篇 |
1991年 | 100篇 |
1990年 | 101篇 |
1989年 | 66篇 |
1988年 | 72篇 |
1987年 | 73篇 |
1986年 | 52篇 |
1985年 | 53篇 |
1984年 | 38篇 |
1983年 | 22篇 |
1982年 | 21篇 |
1981年 | 7篇 |
1979年 | 19篇 |
1977年 | 9篇 |
1972年 | 10篇 |
1971年 | 7篇 |
1970年 | 8篇 |
1969年 | 9篇 |
1968年 | 8篇 |
排序方式: 共有5127条查询结果,搜索用时 15 毫秒
991.
Correct positioning of the endocardial lead in the apex of the right ventricle during the insertion of an implantable cardiodefibrillator
(ICD) under general anesthesia, when cardiac function is generally poor, is most important. We describe herein a method of
using intraoperative esophageal echocardiography in combination with fluoroscopy to confirm fixation of the endocardial ICD
lead in the right ventricular apex.
Received: August 18, 2000 / Accepted: March 6, 2001 相似文献
992.
Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism. 总被引:15,自引:3,他引:12
下载免费PDF全文
![点击此处可从《Blood》网站下载免费的PDF全文](/ch/ext_images/free.gif)
C M Ulrich Y Yasui R Storb M M Schubert J L Wagner J Bigler K S Ariail C L Keener S Li H Liu F M Farin J D Potter 《Blood》2001,98(1):231-234
This study investigated whether a polymorphism in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene (C677T) modifies responses to methotrexate (MTX) in patients undergoing bone marrow transplantation. About 10% to 12% of the population carry the MTHFR TT genotype (enzyme activity, 30% of wild type [CC]). Patients (n = 220) with chronic myelogenous leukemia underwent marrow allografts and were given a short course of MTX. MTX toxicity measures included the oral mucositis index (OMI), speed of engraftment (platelet and granulocyte counts), and bilirubin. Patients with lower MTHFR activity (TT genotype) had 36% higher mean OMI during days 1 to 18 (+5.7, P =.046) and 20% higher OMI between days 6 and 12 (+3.8, P =.27). Platelet counts recovered more slowly among patients with the TT genotype compared to wild type (24% slower recovery to 10 000 platelets/microL, P =.23; 34% slower to 20 000/microL, P =.08). Patients with decreased MTHFR activity appear at risk of higher MTX toxicity. Because of the high prevalence of the TT genotype, these results may have implications for MTX dosage. 相似文献
993.
994.
995.
Kazuhisa Okamoto Masaaki Kodama Kazuhiro Mizukami Tadayoshi Okimoto Hisanori Abe Ryo Ogawa Kensuke Fukuda Osamu Matsunari Yuka Hirashita Yasuhiro Wada Masahide Fukuda Kazunari Murakami 《Journal of Clinical Biochemistry and Nutrition》2021,69(2):216
In this study, the level of cell damage were analyzed immunohistochemically to clarify the association between nodular gastritis and undifferentiated gastric cancer. Thirty patients of nodular gastritis were enrolled as the nodular gastritis group. Thirty patients of non-nodular gastritis were enrolled as the control group. They were evaluated according to the updated Sydney system and used for immunohistochemical staining (p53, Ki-67, E-cadherin, and 8-OHdG). The scores based on the updated Sydney system were significantly higher in the nodular group than in the non-nodular group for histologically assessed inflammation and activity in the gastric corpus (1.91 ± 0.77 vs 1.58 ± 0.60, p = 0.049, 0.83 ± 0.81 vs 0.44 ± 0.64, p = 0.032). On immunostaining, the detection of E-cadherin was lower in the nodular group for both the antrum (1.0 ± 0.62 vs 1.47 ± 0.85, p = 0.047) and the corpus (1.16 ± 0.81 vs 1.48 ± 0.71, p = 0.043) and the p53 labeling index of the gastric corpus was higher in the nodular group than in the non-nodular group (3.06 ± 1.94 vs 2.03 ± 1.99, p = 0.015). Nodular gastritis showed significant severe inflammation and immunohistochemical cell damage compared with non-nodular gastritis. These findings may play an important role in the oncogenesis of undifferentiated gastric cancer in nodular gastritis. 相似文献
996.
As reactive oxygen species (ROS) are involved in the pathogenesis of various diseases, superoxide dismutase (SOD) and its mimetic complexes have been intensively studied. Recently, we found that Cu(2)(aspirinate)(4) (Cu(2)(asp)(4)) has both in vitro and in vivo antioxidative activities. We investigated the suppressive effect of Cu(2)(asp)(4) on ROS generation in the skin of hairless mice that were orally administered Cu(2)(asp)(4) and followed by UVA exposure. The results were compared with those obtained from mice that were orally administered Cu(salicylate)(2) (Cu(sal)(2)) or Cu(acetate)(2), (Cu(ace)(2)) and followed by UVA exposure. After confirming that Cu(2)(asp)(4) suppressed ROS generation in the skin, we measured both SOD activity and metallothionein (MT) and SOD protein levels in the whole proteins extracted from the skin of ICR mice that were orally administered Cu(II) compounds. The Cu(2)Zn(2)-SOD activity was enhanced by the administration of Cu(II) compounds; however, no alterations in the protein levels of MT and SOD were observed. Metallokinetics of the paramagnetic Cu(II) species in the circulating blood of rats, as estimated by electron spin resonance (ESR), revealed that among the Cu(II) compounds, the residence time of the Cu(II) species from Cu(2)(asp)(4) was the longest. On the basis of these results, we conclude that Cu(2)(asp)(4) is an orally potent antioxidative compound that suppresses ROS generation in the skin. The residence time of Cu(II) in the blood and the enhanced SOD activity in the skin following the oral administration of Cu(2)(asp)(4) support this conclusion. Here, we propose that Cu(2)(asp)(4) may be used to protect the skin against ROS generation. 相似文献
997.
Fuyuko Takahashi Yoshitaka Hashimoto Ayumi Kaji Ryosuke Sakai Akane Miki Yuka Kawate Takuro Okamura Noriyuki Kitagawa Hiroshi Okada Naoko Nakanishi Saori Majima Takafumi Senmaru Emi Ushigome Masahide Hamaguchi Mai Asano Masahiro Yamazaki Michiaki Fukui 《Nutrients》2021,13(9)
Salt intake is often estimated by the amount of sodium excreted in urine, and miso has been reported to increase it. This cross-sectional study investigated the relationship between obesity and high estimated salt intake with and without habitual miso consumption. Estimates of salt intake (g/day) were calculated using urinary sodium excretion, and a high estimated intake was defined as greater than the median amount of 9.5 g/day. Participants were divided into four groups based on estimated salt intake and miso consumption. Among 300 people, the proportions of obesity were 77.8% (n = 14/18), 40.2% (n = 53/132), 26.0% (n = 33/127), and 34.8% (n = 8/23) in the (+/−), (+/+), (−/+), and (−/−) groups of high estimated salt intake/habitual miso consumption, respectively. Compared with the (+/−) group, the adjusted odds ratios for obesity were 0.07 (95% confidence interval (CI): 0.02–0.26, p < 0.001), 0.16 (95% CI: 0.03–0.76, p = 0.022), and 0.14 (95% CI: 0.04–0.51, p = 0.003) in the (−/+), (−/−), and (+/+) groups, respectively. The presence of obesity was not much higher in people with high estimated salt intake with habitual miso consumption than that in people without. Clinicians should be aware that miso consumption promotes salt excretion, which may lead to an apparently higher estimated salt intake than actual. 相似文献
998.
Hidefumi Mimura Hiroyasu Fujiwara Takao Hiraki Hideo Gobara Takashi Mukai Tsuyoshi Hyodo Toshihiro Iguchi Kotaro Yasui Yoshihiro Kimata Susumu Kanazawa 《European radiology》2009,19(10):2474-2480
The aim of this study was to retrospectively evaluate the safety and efficacy of polidocanol sclerotherapy in pain relief for painful venous malformations (VMs). Thirty-one patients with painful VMs underwent polidocanol sclerotherapy. Pain intensity was assessed with an 11-point verbal numerical rating scale. Sclerotherapy was technically successful in 58 (98.3%) of 59 sessions. Twenty-six (89.7%) out of 29 patients experienced an improvement in pain after sclerotherapy at follow-up, a mean of 46 months after treatment. The mean pain score improved from 6.6?±?2.5 before treatment to 2.4?±?2.9 after treatment (P <.001). The factors that significantly influenced the therapeutic effect were size of lesion (P?=?.008), margin of lesion (P?=?.006), and stasis of sclerosant (P?=?.032). Adverse events included hypotension and bradycardia during the procedure. No major complication occurred. Polidocanol sclerotherapy is safe and most efficacious in providing pain relief for patients with small VMs (equal to or less than 10 cm in diameter), VMs with a well-defined margin, and VMs with good stasis of sclerosant during sclerotherapy. 相似文献
999.
Miki Okamoto Yoshiyuki Okano Mai Okano Masahide Yazaki Ayano Inui Toshihiro Ohura Kei Murayama Yoriko Watanabe Daisuke Tokuhara Yasuhiro Takeshima 《Nutrients》2021,13(9)
Citrin deficiency is characterized by a wide range of symptoms from infancy through adulthood and presents a distinct preference for a diet composed of high protein, high fat, and low carbohydrate. The present study elucidates the important criteria by patients with citrin deficiency for food selection through detailed analysis of their food preferences. The survey was conducted in 70 citrin-deficient patients aged 2–63 years and 55 control subjects aged 2–74 years and inquired about their preference for 435 food items using a scale of 1–4 (the higher, the more favored). The results showed that the foods marked as “dislike” accounted for 36.5% in the patient group, significantly higher than the 16.0% in the controls. The results also showed that patients clearly disliked foods with 20–24 (% of energy) or less protein, 45–54% (of energy) or less fat, and 30–39% (of energy) or more carbohydrate. Multiple regression analysis showed carbohydrates had the strongest influence on patients’ food preference (β = −0.503). It also showed female patients had a stronger aversion to foods with high carbohydrates than males. The protein, fat, and carbohydrate energy ratio (PFC) of highly favored foods among patients was almost the same as the average PFC ratio of their daily diet (protein 20–22: fat 47–51: carbohydrates 28–32). The data strongly suggest that from early infancy, patients start aspiring to a nutritional balance that can compensate for the metabolism dissonance caused by citrin deficiency in every food. 相似文献
1000.
Tatsuro Joh Kazuto Sigematu Jun-ichi Yasui Yumi Takasaki Masayuki Tawara Osamu Takahara Masao Tomonaga 《Case reports in oncology》2009,2(3):184-188
We present here a case of dorsal column degeneration in a female patient with multiple myeloma following exposure to bortezomib. Two days after intravenous administration of a first course of bortezomib 1 mg/m2, the patient developed rapidly-progressive numbness, pain and muscle weakness in the bilateral upper and lower limbs. Following gancyclovir treatment of subsequent cytomegalovirus viremia, the patient went on to receive a course of EPOCH (etoposide 50 mg/m2/day on days 1–4, vincristine 0.4 mg/m2/day on days 1–4, doxorubicin 10 mg/m2/day on days 1–4, cyclophosphamide 750 mg/m2/day on day 6, and prednisolone 60 mg/m2/day on days 1–6). Shortly thereafter, the patient developed bilateral Aspergillus pneumonia. Despite treatment with appropriate antifungal agents, the patient died from respiratory failure due to bilateral diffuse alveolar damage of the lungs and without recovery of severe sensory and motor neuropathy prior to her death. Post mortem examination revealed spongy degeneration of the dorsal column from the medulla oblongata to the cervical spinal cord. Bortezomib-associated peripheral neuropathy in patients with multiple myeloma has been commonly reported but appears to resolve in a majority of these patients after dose reduction or discontinuation. We believe this to be the first report of spinal cord abnormalities in a patient with multiple myeloma treated with bortezomib. Further investigation is required to ascertain the exact mechanism of this central neurotoxic effect and to identify appropriate neuroprotective strategies.Key Words: Bortezomib, Multiple myeloma, Peripheral neuropathy, Dorsal column degeneration 相似文献